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The cystic fibrosis transmembrane conductance regulator (CFTR) requires dynamic fluctua-
tions between states in its gating cycle for proper channel function, including changes in the
interactions between the nucleotide-binding domains (NBDs) and between the intracellular
domain (ICD) coupling helices and NBDs. Such motions are also linked with fluctuating
phosphorylation-dependent binding of CFTR’s disordered regulatory (R) region to the NBDs
and partners. Folding of CFTR is highly inefficient, with the marginally stable NBD1 sam-
pling excited states or folding intermediates that are aggregation-prone. The severe CF–
causing F508del mutation exacerbates the folding inefficiencyof CFTR and leads to impaired
channel regulation and function, partly as a result of perturbed NBD1–ICD interactions and
enhanced sampling of these NBD1 excited states. Increased knowledge of the dynamics
within CFTR will expand our understanding of the regulated channel gating of the protein as
well as of the F508del defects in folding and function.
Understanding how proteins function oftenrequires knowledge of structure and con-
formational stability and dynamics. Unlike me-
chanical parts, proteins are self-assembling dy-
namic components that require flexibility for
function. Conformational changes are required
during the folding process and for progression
through functional cycles. Aberrations in stabil-
ity and/or dynamics can lead to protein mis-
folding or dysfunction, primary causes of many
diseases including cystic fibrosis (CF). Changes
in stability can be independent of significant
structural changes to a protein’s ground state,
as is the case for the cystic fibrosis transmem-
brane conductance regulator (CFTR). As dis-
cussed in previous articles, deletion of F508
in CFTR (F508del), widely observed in CF pa-
tients, results in a significant decrease in folding
and processing efficiency as well as in gating
defects (Riordan et al. 1989; Cheng et al. 1990;
Dalemans et al. 1991; Drumm et al. 1991). An
early indication that the mutation does not ste-
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rically inhibit proper folding or remove a criti-
cal structural component was the observation
that the processing efficiency could be signi-
ficantly improved by expressing the protein at
268C instead of 378C (Denning et al. 1992). The
mutation decreases CFTR’s thermostability, but
a small amount of properly processed mutant
protein does arrive at the cell membrane and has
residual activity. Although the mutation does
not prohibit the conformations required for
proper gating, the activity of F508del is rapid-
ly lost with increase in temperature, indicating
that the mutation affects CFTR stability and dy-
namics. The pathology is characterized by the
inefficiency of folding and processing and a re-
duction in the lifetime of the open conforma-
tion during the gating cycle.
CFTR comprises two repeated units, each
containing a membrane-spanning domain
(MSD1 and MSD2) and a cytoplasmic nucleo-
tide-binding domain (NBD1 and NBD2) (Rior-
dan et al. 1989). The carboxyl terminus of NBD1
is connected to the amino terminus of MSD2
via a 200-residue intrinsically disordered regu-
latory (R) region (Fig. 1) (Riordan et al. 1989;
Dulhanty and Riordan 1994; Ostedgaard et al.
2000). Folding of wild-type (WT) CFTR is gen-
erally found to be inefficient, although efficiency
varies with cell type (Lukacs et al. 1994; Ward
and Kopito 1994; Varga et al. 2004). The domi-
nant F508del mutation exacerbates the inef-
ficiency. Improperly folded CFTR is retained
by endoplasmic reticulum (ER) quality control
mechanisms, a process that is readily measured
by monitoring the degree of glycosylation by
SDS polyacrylamide gel electrophoresis (Cheng
et al. 1990). Although some reports indicate that
CFTR domains initiate their folding cotransla-
tionally in an independent fashion (Kleizen et al.
2005; Hoelen et al. 2010), interdomain interac-
tions are required for final processing and escape
from the ER quality control machinery (Cui
et al. 2007). Notably, acquisition of a protease-
resistant NBD2 fold has been shown to re-
quire appropriate interactions with the preced-
ing domains (Du et al. 2005). Deletion of F508
in NBD1 negatively affects proper folding of
NBD2, possibly by introducing a nonphysiolog-
ical tight interaction between NBD1 and NBD2
(Du et al. 2005). Interestingly, NBD2 is not
required for transportation out of the ER (Cui
et al. 2007) or CFTR gating (Wang et al. 2010b).
Misfolding of NBD2 in F508del may result
in CFTR being retained in the ER by the quality
control machinery, unable to proceed to the cell
surface.
At the cell surface, MSD1 and MSD2 of
CFTR form a regulated anion channel that cy-
cles through a closed state, an open-ready state,
and an open state. The cytoplasmic extensions
of the transmembrane helices form helical bun-
dle structural regions, which collectively consti-
tute the intracellular domains (ICDs) believed
to transmit information from the NBDs to the
transmembrane pore. Gating of the channel is
known to require phosphorylation of the R re-
gion (Cheng et al. 1991; Bergeret al. 1993), bind-
ing of ATP at the two sites at the NBD hetero-
dimer interface, and hydrolysis of ATP at the
site formed by the ATP-binding core of NBD2
(Cheung et al. 2008). Phosphorylation is be-
lieved to relieve R-region inhibition of channel
opening, but the conformational change effect-
ed by the phosphorylation is poorly understood.
NBD1 and -2 form a functional dimer (reviewed
by Cheung et al. 2008), but the changes in the
dimer conformation that open and close the
channel are also poorly understood.
Here we will discuss gating cycle dynamics,
the dynamics of the R region and NBD1, and
changes in CFTR’s dynamic behavior resulting
from deletion of F508.
FULL-LENGTH CFTR
Unlike the other ATP-binding cassette (ABC)
transporters to which it is related, CFTR func-
tions as a channel rather than as an active trans-
porter (Anderson et al. 1991). Despite this
difference, CFTR shows significant sequence
similarity with ABC transporters (Riordan et
al. 1989) and likely undergoes similar confor-
mational rearrangements. As a channel, CFTR
exists in a closed conformation, which does not
permit chloride transport, and an open con-
formation, which permits rapid chloride flow
through the pore formed by the MSDs. Single-
channel recordings of CFTR indicate that the
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channel has two phases, a burst interval, during
which the channel is open but flickers rapidly
through a closed state, and an interburst inter-
val, during which the channel is closed (Winter
et al. 1994), indicating that CFTR has at least
three conformations: a closed state, an open
state, and an open-ready state. The open-ready
state does not allow chloride flow but, unlike the
closed state, is poised to rapidly transition to the
open state. As a large polytopic membrane pro-
tein containing multiple domains and disor-
dered segments, full-length CFTR has resisted
efforts to directly resolve the structure of any of
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Figure 1. Schematic representation of nonphosphorylated (A) and phosphorylated (B) CFTR. The membrane-
spanning domains (MSDs) and nucleotide-binding domains (NBDs) are shown in gray and blue, respectively.
The R region, regulatory insertion (RI), and regulatory extension (RE) are shown in red. The intracellular
domains (ICDs) are shown in orange or purple with the coupling helices or intracellular loops (ICLs) identified.
The elbow helices (EHs) are shown in green. Intramolecular interactions are indicated by dashed arrows.
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Insight into the structure and dynamics of full-
length CFTR has come from crystal structures
of related ABC transporters, molecular mod-
eling, cross-linking studies, electrophysiology
experiments, and electron microscopy. In this
section we review what is known about the dy-
namics of full-length CFTR as it passes through
the gating cycle.
CFTR-related ABC transporters represent-
ing different stages of the transport cycle have
been crystallized (Dawson and Locher 2006;
Hollenstein et al. 2007; Pinkett et al. 2007;
Ward et al. 2007). The structures suggest that
the MSDs collectively form two discrete helical
bundles that move with respect to each other,
forming alternately outward- and inward-facing
conformations. In the outward-facing confor-
mation (as exemplified by the Sav1866 structure
[Dawson and Locher 2006]), the helical bun-
dles point away from each other on the extracel-
lular side of the protein, diverging near the mid-
point of the membrane, and the NBDs form
tight dimers with both composite ATP-binding
sites tightly juxtaposed and nucleotide-filled
(Fig. 2). In the inward-facing conformation (as
exemplified by the MsbA nucleotide-free struc-
tures [Ward et al. 2007]), the helical bundles
point away from each other on the intracellular
side of the membrane and the NBDs are at least
partially separated and nucleotide-free (Hol-
lenstein et al. 2007; Ward et al. 2007). A range
of separation is observed for the inward-facing
conformation, suggesting a great deal of flexi-
bility in the inward-facing conformation (Ward
et al. 2007). In the MsbA “open apo” structure,
the NBDs are completely separated. The out-
ward-facing conformation appears to be pro-
moted by nucleotide-induced NBD tight dimer
formation transmitted through an interaction
between the NBDs and the ICDs. The inward-
facing conformation may be triggered by nucle-
otide hydrolysis and release.
The relationship between the inward- and
outward-facing conformations observed in these
crystal structures of related transporters and the








Figure 2. Ribbon diagram representation of the outward-facing conformation of Sav1866 in two orthogonal
views. The subunits of the dimer are shown in blue and purple. Note that the two transmembrane helical bundles
move apart as they near the extracellular side of the membrane (PDB 2HYD [Dawson and Locher 2006]).
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conclusively established. The outward-facing
conformation has been assumed to be represen-
tative of the open conformation of the CFTR
channel in part because it is the nucleotide-
bound state in the observed structures (Mornon
et al. 2009). By analogy, the closed conforma-
tion may be represented by the inward-facing
conformation. ABC transporters operate by an
“alternating access” mechanism (Mitchell 1957;
Jardetzky 1966). They bind substrate in one
conformation and then undergo a conforma-
tional change that allows release of the substrate
on the opposite side of the membrane. The sub-
strate is never able to freely pass through the
transporter. Because CFTR is closely related
to these ABC transporters, it is envisioned that
it undergoes a similar conformational change.
However, as it is a channel and not an active
transporter, it is not clear that the analogy holds
and that CFTR maintains the same dynamic
modes. In particular, CFTR is believed to have
three different conformations rather than two,
although one or more of these conformations
may be very similar. As with other ABC trans-
porters, channel gating has been shown to be
tightly coupled to ATP hydrolysis (Csanady et
al. 2009), but the effect of nucleotide binding on
the position of the NBDs with respect to each
other has not been resolved. Channel opening
may require induced dimerization or a more
moderate conformational change in preexisting
dimers (Smith et al. 2002; Dawson and Locher
2006; Jones and George 2007, 2009).
Electron microscopy images obtained from
single-particle analysis of noncrystalline as well
as two-dimensional crystals of CFTR in a nucle-
otide-free state and a nucleotide-bound phos-
phorylated state lend some support to CFTR
having inward- and outward-facing conforma-
tions (Rosenberg et al. 2004; Awayn et al. 2005;
Zhang et al. 2009). The images suggest that in the
absence of nucleotide the helical bundles have
a greater separation on the cytoplasmic side,
whereas in the nucleotide-bound form the
helical bundles are closer to the outward-facing
model. The role of nucleotide binding and con-
formational changes at the NBDs is not discern-
ible from these low-resolution images. Howev-
er, the images do suggest that the NBDs do not
completely separate as they do in one of the
MsbA structures (open apo) (Ward et al. 2007).
The crystal structures of Sav1866 and MsbA,
bacterial ABC transporters, were used to con-
struct structural models of the opened and
closed states of full-length CFTR that have
been partially validated experimentally (Mor-
non et al. 2008, 2009; Serohijos et al. 2008a; Al-
exander et al. 2009; Huang et al. 2009; Kanelis
et al. 2010; Moran 2010). The channel pore ar-
chitecture has been experimentally probed us-
ing cysteine mutants and thiol-reactive reagents
to determine the accessibility of particular sites
in the pore. Taken together, these studies are
strongly supportive of the Sav1866-based ho-
mology models (Zhang et al. 2005; Fatehi and
Linsdell 2008; Alexander et al. 2009). They show
a pore that is wide on the extracellular side
and becomes more inaccessible to molecular
probes, especially anionic probes, moving to-
ward the cytoplasmic surface. There is also evi-
dence that the pore architecture undergoes
significant conformational change during the
gating cycle (Zhang et al. 2005; Fatehi and Lins-
dell 2008). Activation of the channel (by forsko-
lin and 3-isobutyl-1-methylxantine [IBMX])
appears to significantly enhance access of anions
to the pore (Fatehi and Linsdell 2008). Accessi-
bility for cations is less stringent, and even large
organic cations can reach cysteines introduced
into the putative inner vestibule of the pore in
the inactive state. Fatehi and Linsdell further
propose that there are two functionally distinct
closed states: the inactivated channel and the “ac-
tivated but still closed” channel conformation.
They suggest that the latter conformation is acti-
vated by protein kinase A (PKA) but still requires
ATP-dependent conformational changes at the
NBDs to open the channel to chloride flow. The
activated but still closed conformation is like-
ly related to the open-ready conformation ob-
served in single-channel gating studies.
The homology models also identify specific
interactions between the ICDs and the NBDs,
which have been tested experimentally by chem-
ical cross-linking studies. At a gross level, these
studies confirm close interactions between the
NBDs and the ICD “coupling helices” that lie at
the NBD interface (called ICLs or CLs), which
Dynamics Intrinsic to CFTR Function and Stability



















supports the notion that the positioning of the
MSDs is controlled by interactions between the
NBDs and ICLs (Serohijos et al. 2008a). At a
specific level, cross-linking studies confirm in-
teractions between ICL1, ICL3, and ICL4 and
NBD1 (He et al. 2008, 2010). These studies also
show that cross-linking NBD1 to ICL3 or -4, but
not ICL1, strongly inhibits channel gating (He
et al. 2008), a result that suggests that the NBD–
ICL interface must change during the gating
cycle. Similar results were noted for NBD2–
ICL interfaces (He et al. 2008). Significant flex-
ibility in NBD–ICL interactions is also indi-
cated by the large distribution of linker lengths
that can cross-link particular NBD–ICL cys-
teine pairs introduced into a Cys-less CFTR
(Serohijos et al. 2008a). Although cross-linking
can inhibit channel gating, suggesting a require-
ment for flexibility, NBD1–ICL4 and NBD2–
ICL2 cross-linking are not strongly influenced
by PKA phosphorylation or adenosine 50-(b, g-
imido)triphosphate (AMPPNP) binding. These
findings imply that the interfaces between
NBD1 and ICL4 and between NBD2 and ICL2,
respectively, remain relatively tight during the
gating cycle (He et al. 2008). On the other hand,
nuclear magnetic resonance (NMR) evidence
indicates that ICL1 only binds to the PKA-phos-
phorylated state of mouse NBD1 (mNBD1)
(phosphorylated on the RI and RE; see below)
(Kanelis et al. 2010), suggesting that activation
of CFTR by PKA does alter the NBD1–ICL1
interaction.
A critical point made by these models is that
F508 forms part of the interface between NBD1
and ICL4. As discussed below, deletion of F508
has a limited effect on the ground state structure
of NBD1 itself. The structure of the mutant
NBD1 is the same as that of the WT, with the
exception of altered surface properties in the
vicinity of F508 and structural rearrangement
of the F494–W496 loop. Deletion of F508 and
the resulting change in NBD1 surface proper-
ties were hypothesized to disrupt the interac-
tion with the ICL4 coupling helix that contains
R1070. In F508del CFTR, mutation of V510,
which is near the position of F508 in the WT,
to aspartic acid partially corrects the CF defect
and promotes CFTR maturation (Loo et al.
2010). The V510D mutation likely introduces
a salt bridge with R1070, strengthening this in-
terface. These data support the hypothesis that
F508 disrupts this critical ICL4 interaction. Sim-
ilar results are seen with an R1070W mutation,
which might be expected to enhance the hydro-
phobic contacts at this interface or fill the void
introduced by deletion of F508, or with a com-
bined R1070D/V510R mutation, which would
reverse the proposed salt bridge (Farinha et al.
2010; Loo et al. 2010). These additional muta-
tions support the idea that the F508del pheno-
type can be attributed at least partially to a
disruption of this interface, although as we dis-
cuss below, the V510D mutation also thermo-
dynamically stabilizes NBD1 itself. The data
on the V510D mutation indicate that interdo-
main interactions between NBD1 and ICL4 are
required for proper folding and maturation of
CFTR. Thus, restoring this interface via thera-
peutic compounds designed to enhance this
interaction might be expected to partially cor-
rect the F508del defect. Examining the effects of
stabilizing and destabilizing mutations at this
interface may be a useful approach for explor-
ing the dynamics of this interface through the
gating cycle.
Molecular modeling of CFTR based on
related ABC transporters, electron microscopy,
cross-linking, and electrophysiology experi-
ments have yielded significant insight into the
overall organization and dynamics of full-length
CFTR. Disruption of the NBD1–ICL4 inter-
action by F508del provides a partial answer
for how the mutation disrupts processing and
gating. Further explanation of how F508del dis-
rupts CFTR processing arose from a closer look
at the dynamics and thermodynamics of the iso-
lated NBDs. CFTR’s processing efficiency has
been shown to be related to the instability and
aggregation tendencies of the NBDs. Deletion
of F508, which is found in NBD1, further de-
creases the stability of NBD1. The R region,
which is an important site of phosphodepend-
ent regulation, is also highly dynamic. The high-
ly dynamic natures of the R region and NBD1
are evidence of a shallow energetic landscape,
with an equilibrium between multiple acces-
sible conformations that is sensitive to subtle
P.A. Chong et al.



















sequence changes. As a result of this thermody-
namic sensitivity, NBD1 dynamics and interac-
tions are highly responsive to destabilizing and
stabilizing mutations. The next section focuses
on the complex dynamics of the R region and
NBD1 and how these impact CFTR processing
and function.
CFTR REGIONS AND DOMAINS
R Region
The R region is the principal physiological reg-
ulator of CFTR function, and its mechanism of
action has been the focus of intense study. A
dominant view is that the nonphosphorylated
R region inhibits channel opening. This view is
supported by evidence indicating that removal
of portions of the R region encompassing resi-
dues 760–783 or 817–838 produces channels
that open without activation by phosphoryla-
tion (Baldursson et al. 2001; Xie et al. 2002).
Activation of the channel requires PKA phos-
phorylation of multiple serines (there are .10
sites), most of which are in the R region (Pic-
ciotto et al. 1992; Chappe et al. 2004), although
there are also protein kinase C (PKC) (Picciotto
et al. 1992; Chappe et al. 2004) and inhibitory
adenosine monophosphate-stimulated kinase
(AMPK) sites (King et al. 2009; Kongsuphol
et al. 2009). Critically, there is no requirement
for phosphorylation at any one specific site
(Cheng et al. 1991; Rich et al. 1993). Phosphor-
ylation at an increasing number of sites en-
hances the level of channel activation in a
roughly additive manner (Chang et al. 1993;
Rich et al. 1993; Wilkinson et al. 1997). The R
region is disordered, as shown by NMR and
circular dichroism experiments (Dulhanty and
Riordan 1994; Ostedgaard et al. 2000; Baker
et al. 2007), providing a key component in un-
derstanding the plasticity in its behavior.
As a disordered protein segment, the R re-
gion is highly dynamic and does not assume a
single ground state conformation whether or
not it is phosphorylated. Rather, NMR experi-
ments indicate that the isolated R region rapidly
exchanges between many different conforma-
tions (Baker et al. 2007). Individual segments
of the R region can transiently populate second-
ary structural elements such as a-helices (Baker
et al. 2007). Phosphorylation reduces the global
a-helical content of the R region, which like-
ly alters R-region binding preferences. R-region
structural ensembles generated using discrete
molecular dynamics (MD) simulations suggest
that phosphorylation increases the R-region ra-
dius of gyration (Hegedus et al. 2008); how-
ever, NMR-based diffusion measurements in-
dicate that phosphorylation actually decreases
the hydrodynamic radius of the R region (Bo-
zoky et al. 2010). Electron microscopy images
provide evidence of a high-variability region of
density adjacent to the ICDs that is not account-
ed for by the Sav1866 protein structure and
suggests one possible location for a dynamic R
region (Zhang et al. 2009). Electron microscopy
images of nanogold-labeled CFTR also support
a position of the R region near the ICDs.
R-region flexibility makes phosphorylation
sites highly accessible and is likely to play an
important role in its regulatory function. Dis-
ordered proteins often function as protein in-
teraction hubs, which integrate protein inputs
(Dunker et al. 2005). Besides interactions with
PKA, PKC, and AMPK, the R region has been
reported to interact with NBD1, NBD2, the dis-
ordered carboxy-terminal portion of CFTR,
and the STAS domain of SLC26A3 in a dynamic
fashion (Bozoky et al. 2010). NMR evidence for
the interactions indicates that they are transient
(lifetimes of less than milliseconds) and that
multiple sections of the R region are involved.
The R region may serve to integrate various cel-
lular control parameters to enable generation of
an appropriate level of channel response. A par-
ticularly important set of R interactions may be
with the NBDs. The R region interacts with the
NBDs and causes changes on multiple NBD1
surfaces, including some that overlap with the
proposed NBD2 interaction interface. R-region
phosphorylation was shown to decrease binding
to NBD1 (Baker et al. 2007), possibly by reduc-
ing the population of NBD1-interacting a-he-
lices. It is important to note that the data sug-
gest that multiple portions of the R region
interact with the NBDs in a dynamic fashion.
No specific segments of the R region have been
Dynamics Intrinsic to CFTR Function and Stability



















identified as critical for NBD1 interaction. This
points to a model in which various segments
of the nonphosphorylated R region bind to
the NBD dimer interface in a transient manner
and sterically inhibit formation of a productive
heterodimer, thus preventing channel opening.
Phosphorylation reduces R region–NBD inter-
actions, facilitating dimer formation.
Another hypothesis is that the R region di-
rectly controls the position of the MSDs in the
gating cycle (Hegedus et al. 2008), rather than
exerting its regulatory effect through the NBDs.
In this distance constraint model, the size of the
R-region ensemble directly controls the physi-
cal separation of the MSDs through its amino-
terminal tether to NBD1 and its carboxy-ter-
minal tether to MSD2. Consistent with this,
channel gating may not require NBD dimeri-
zation in and of itself (Cui et al. 2007; Wang
et al. 2007, 2010b). Channels with NBD2 re-
moved have been found to have a low open
probability (Cui et al. 2007; Wang et al. 2007;
Zhang et al. 2011). Electron microscopy posi-
tioning of the R region near to the ICDs is also
consistent with this idea. Computer models of
phosphorylated and nonphosphorylated R re-
gions and their interactions with various bind-
ing partners based on NMR and small-angle X-
ray scattering data are in progress to more clear-
ly define the R-region conformational ensemble
within the context of CFTR.
NBD1
As NBD1 is the site of the dominant F508del
mutation, this domain has been the subject of
intensive structural, dynamic, and thermody-
namic analyses. Crystal structures of NBD1
show that it is divided into the three basic
regions seen in nucleotide-binding domains
of other ABC transporters (Lewis et al. 2004,
2005; Thibodeau et al. 2005; Atwell et al.
2010): theb-sheet subdomain, the ATP-binding
core, and the a-helical subdomain (Fig. 3). The
ATP-binding core contains the Walker A and
Walker B motifs and forms the primary con-
tacts with ATP in the monomeric form. Two
additional elements containing phosphoryla-
tion sites could be resolved in some structures:

















Figure 3. Ribbon diagram representation of CFTR NBD1. The ATP-binding core, a-subdomain, and b-sub-
domain are shown in gray, blue, and green, respectively. The regulatory extension (RE) and the amino and
carboxyl termini of the regulatory insertion (RI) are shown in pink. The central portion of the RI is disordered
and is not shown. ATP and magnesium are shown in orange and yellow, respectively. Other features, including
the structurally diverse region (SDR), the Q-loop within thea-subdomain, and helices 8 and 9 (H8 and H9), are
indicated by the labeled arrows. (PDB 2BBO [Lewis et al. 2010].)
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by the first 30 residues of the R region and is
alternatively classified as the carboxyl terminus
of NBD1, and the regulatory insertion (RI), a
30-residue, largely disordered insertion be-
tween the first and second b-strands unique to
CFTR’s NBD1. Analysis of several published
NBD1 crystal structures reveals that F508del
does not grossly perturb the structure of the
ground state of the core NBD1 domain. It
only causes significant structural changes near
the location of the mutation (Lewis et al. 2004,
2005, 2010; Thibodeau et al. 2005; Atwell et al.
2010). Nevertheless, several lines of evidence
suggest that the mutation does alter NBD1 dy-
namic modes or excited states.
The RI and RE show the most pronounced
conformational variability in comparisons of
the different crystal structures (Lewis et al.
2010), strongly suggesting that they are mobile.
Residues 654–669 in the RE consistently form
an a-helix, but the helix packs in different posi-
tions in the various crystal structures. One dom-
inant interaction site is near the Walker A motif,
an interaction that would inhibit NBD hetero-
dimerization. Hydrogen/deuterium (H/D) ex-
change experiments show that the amide pro-
tons in thisa-helix readily exchange in solution,
indicating that the helix is unstable (Lewis et al.
2010). NMR-derived chemical shifts provide
evidence that the preceding two helices (H8
and H9) also exchange with a coil conformation
(Hudson et al. 2012). Crystal structures show
short helices at both the amino and carboxyl
termini of the RI; however, electron density is
absent for the central portion, implying that this
region of the RI is disordered. The two short
helices at either end of the RI are also found in
different orientations in the crystal structures,
again implying mobility. The RI affects the ge-
ometry of ATP binding in some structures
(Lewis et al. 2004). H/D exchange experiments
confirm that amide protons in the RI are highly
solvent-exposed, indicating that the terminal
helices and interaction with ATP are not stable.
The RI and RE contain phosphoregulatory
sites at residues 422, 660, and 670 (Townsend
et al. 1996; Csanady et al. 2005). NMR spectral
changes caused by phosphorylation of mNBD1
were shown to be similar to changes caused by
removal of the RE, indicating that phosphoryla-
tion disrupts interactions between the NBD1
core and the RE (Kanelis et al. 2010). Phosphor-
ylation also seems to disrupt the RI interaction
with the NBD1 core, so that the RI appears to
sample more disordered conformations. Kanelis
et al. proposed a model in which the RE and RI
form transient inhibitory interactions with the
NBD1 core, much like the R region does. These
inhibitory interactions reduce dimerization
probability and are in turn inhibited by phos-
phorylation. Phosphorylation of the RI may also
enhance ATP affinity by disrupting the RI’s in-
teraction with the ATP-binding core, a possible
regulatory mechanism. Deletion of F508 reduces
the magnitude of the changes resulting from
phosphorylation, suggesting that the phosphor-
ylated RI and RE interact more strongly with the
NBD1 core in the mutant (Kanelis et al. 2010).
This strengthened interaction was hypothesized
to reduce NBD heterodimerization propensity
and channel open probability. It was also ob-
served that F508del inhibits the interaction be-
tween ICL1 and the phosphorylated mNBD1.
Collectively, these data suggest that F508del al-
ters interactions between the regulatory regions
and NBD1 in the absence of large structural
changes to the ground state of NBD1, implying
that properties other than the altered surface
near F508 have been changed. These additional
altered properties must result from changes in
dynamic modes or excited states that are not ob-
served in the static crystal structures.
NMR evidence also indicates that NBD1 is
a highly dynamic protein with extensive mo-
tion in the millisecond-to-picosecond time-
scales. Even the ATP-binding core of the protein
experiences millisecond-to-microsecond time-
scale dynamics, as shown by loss of NMR signal
intensities (Chong and Forman-Kay 2010; Ka-
nelis et al. 2010). The exchanging population
in the ATP-binding core is likely to be small,
as H/D exchange reveals that exchange in this
region is relatively slow (Lewis et al. 2010). Anal-
ysis of crystallographic data indicates that the
a-subdomain has variable orientations with
respect to the ATP-binding core (up to 78 rota-
tion), strongly suggesting a flexible linkage
(Lewis et al. 2010). This was not unexpected,
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because the orientation of the a-subdomain
with respect to the ATP-binding core has been
shown to be nucleotide-dependent in other
ABC transporters (Smith et al. 2002; Jones
and George 2007, 2009). This rotation is postu-
lated to play a critical role in the power stroke
of ABC transporters (Hopfner et al. 2000;
Smith et al. 2002), but its role in CFTR is un-
known. Whether the CFTRa-subdomain reori-
ents in response to nucleotide changes is also
unknown. Conformational variability in the Q-
loop, which links the ATP-binding core subdo-
main with the amino terminus of the a-subdo-
main, is not observed in the crystal structures,
possibly because most of the structures have
bound ATP or a nonhydrolyzable analog. One
MD study indicates that deletion of F508 desta-
bilizes the Q-loop, causing it to dissociate from
the body of the domain, and leads to a-subdo-
main orientational freedom (Wieczorek and
Zielenkiewicz 2008). Crystallographic confor-
mational variability and/or high B-factors are
observed for the 509–511 loop, a portion of the
structurally diverse region (SDR residues 541–
547) that likely interacts with NBD2, the Wal-
ker B loop (572–579), the a-helix following
the H-loop, and the loop preceding the Walker
B b-strand. High B-factors are observed for
the final b-strand of the b-subdomain, which
likely binds to the ICDs. Comparison of H/D
exchange for WTand F508del indicates that the
mutation results in a significant increase in H/D
exchange rate in the sequence vicinity of the
508 mutation, extending from before residue
504 to beyond residue 517 (Lewis et al. 2010).
Changes in the H/D exchange rate elsewhere in
the domain are minimal, at least when Mg-ATP
is bound to the domain. This is consistent with
the loose packing of the F508 residue and the
variable conformations for this region observed
in the crystal structures. It is also consistent with
the minimal structural changes observed in the
ground state structure on deletion of F508.
Thus, two mechanisms explain how F508del
negatively affects processing and gating. First,
the mutation directly changes the ICL-inter-
acting surface of NBD1, negatively affecting
these interactions that are critical for processing
and likely for gating as well. Second, F508del
changes the dynamic and thermodynamic pro-
perties of NBD1, including enhanced interac-
tions with the RI, the RE, and the R region. This
second mechanism likely involves a change in
the overall energetic landscape of NBD1 on de-
letion of F508, resulting in perturbed excited
states and differential sampling of these excited
states. Because of the changes in the ener-
getic landscape, this second mechanism also re-
lates to the folding and unfolding properties of
NBD1. Several lines of evidence indicate that
the change in the NBD1 energetic landscape is
a key part of the explanation for the negative
effects of F508del.
The nature of a subset of the suppressor
mutations for the F508del defect, in particular,
suggests that NBD1 stability is central to the
defect. F508del causes a substantial, 68C–
78C drop in thermal melting temperature of
purified NBD1 (Protasevich et al. 2010). Many
of the suppressor mutations, like G550E,
R553Q, and R555K (Teem et al. 1993, 1996),
which are relatively distant from the F508 posi-
tion, increase NBD1 thermal stability and re-
verse some of the processing and functional
defects, presumably without reverting the sur-
face changes caused by deletion of F508. V510D,
which may rescue F508del by facilitating the
NBD1–ICL4 interaction, also stabilizes NBD1
(Protasevich et al. 2010), suggesting a dual
mechanism of action. Recently, substitution of
proline residues at key positions in the Q-loop,
the SDR, and the RI in context of the I539T
suppressor mutation has been shown to restore
channel function and thermostability to full-
length F508del CFTR. MD studies support a
role for these proline mutations in reducing
flexibility and increasing the temperatures of
unfolding transitions for F508del NBD1 (Alek-
sandrov et al. 2012). Most convincingly, for a
subset of suppressor mutants, a good correla-
tion is observed between the improvement in
NBD1 stability and CFTR processing efficiency
(Thibodeau et al. 2010; Rabeh et al. 2011).
In addition to stabilizing point mutations,
complete removal of the RI, which is relatively
distant from the a-subdomain, also dramati-
cally enhances the solution stability of NBD1
(Atwell et al. 2010). Furthermore, removal of
P.A. Chong et al.



















the RI has been shown to suppress trafficking
and gating defects associated with F508del (Alek-
sandrov et al. 2010). Not only does removal
of RI improve solution stability of NBD1, it
also restores function to F508del CFTR at phys-
iologically relevant temperatures, as shown by
iodide efflux and electrophysiological measure-
ments (Aleksandrov et al. 2010). Partial removal
of RI did not recapitulate this effect on NBD1
stability and restoration of function, indicating
that the dynamics of RI (residues 401–436)
plays an inhibitory role in CFTR function. As
mentioned earlier, NBD1 crystal structures pre-
sent only portions of the RI, and these in mul-
tiple conformations. The complete RI could not
be resolved because of its intrinsic flexibility.
Discrete MD simulations of NBD1 with a struc-
tural model for the RI revealed that the RI dy-
namically couples different regions of NBD1
(Fig. 4A,B) (Aleksandrov et al. 2010). Residue-
wise root mean square fluctuation (RMSF) dur-
ing the simulation reiterates that the RI is in-
trinsically flexible and dynamic (Fig. 4A). Most
importantly, dynamic coupling exists between
the F508-containing loop and the ATP-binding
core subdomain of NBD1, which is lost on de-
letion of F508 (Fig. 4B). Such coupling is par-
tially restored on deletion of the RI, indicat-
ing that the RI influences the dynamics of the
F508-containing loop (Fig. 4B). Therefore, de-
letion of F508 could cause dynamic effects that
influence the NBD1–ICL3–ICL4 interfaces
and hence perturb the overall gating character-
istics of the channel (Fig. 4C,D). Given that the
structure of NBD1 with and without F508 is not
significantly different, NBD1 dynamics likely
play a crucial role in trafficking, maturation,
and function of CFTR. Based on these results,
one might hypothesize that conformational re-
striction of the RI region in NBD1 would im-
prove maturation, trafficking, and function of
F508del CFTR.
As we have suggested, changes to the NBD1
energetic landscape not only alter its interaction
with regulatory regions, but they also affect its
self-association. Extensive chemical and thermal
denaturation studies monitored by a variety of
biophysical techniques have identified an aggre-
gation-prone, partially unfolded intermediate
state on the unfolding pathway that is enhanced
by F508del (Richardson et al. 2007; Protasevich
et al. 2010; Wang et al. 2010a). F508del does not
seem to affect unfolding of this partially unfold-
ed intermediate, suggesting that the F508 region
is already unfolded in the intermediate. F508
and many suppressor mutations are located in
the a-helical subdomain, implying that the par-
tially unfolded state involves this subdomain
(Wang et al. 2010a). The RI is not located in or
near the a-helical subdomain; however, it still
may affect the conformation of this subdomain.
One possible mechanism is that ATP affinity is
enhanced on removal of the RI. ATP binding in
turn may affect the a-helical subdomain orien-
tation and stability via its interaction with the Q-
loop. A second possibility is dynamic coupling
between the RI and the SDR region as observed
in MD simulations (Aleksandrov et al. 2010).
Deletion of the RI stabilizes the SDR region in
these MD studies and may impart an effect on
NBD1 stability similar to a-helical subdomain
suppressor mutations (Aleksandrov et al. 2010).
The partially unfolded intermediate identified
by the Hunt and Brouillette groups appears
to be aggregation-prone and thus likely reduces
both processing and gating efficiency. A partial-
ly unfolded configuration for thea-subdomain,
which may be similar to that identified by Wang
et al. (2010a), can be observed in MD simula-
tions, suggesting that the dynamics of NBD1 can
be accurately captured using simulations. In ad-
dition, MD folding simulations led to the con-
clusion that F508 deletion alters the kinetics of
NBD1 folding (Serohijos et al. 2008b). These
studies provide atomistic explanations for the
experimentally observed decrease in NBD1 fold-
ing yields on deletion of F508 (Thibodeau et al.
2005). Different folding intermediates are ob-
served and different transient contact patterns
are formed for WT and F508del NBD1 in these
simulations (Serohijos et al. 2008b). In this study,
the H5–S6 loop and the S7–H5 loop near the
a-subdomain–ATP-binding core interface were
found to represent significant structural differ-
ences between WT and F508del NBD1. NMR
dispersion experiments have also identified a
weakly-populated excited state for WT NBD1
protein that is enhanced by F508del (Chong and
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Forman-Kay 2010). The relationship between
the excited states observed by these different
methods and groups is unclear, but collectively
theysupport the notion that F508del profoundly
perturbs the NBD1 energetic landscape.
The nature of some of the NBD1 excited
states might be investigated by analysis of
NBD1 fragments that have been found to be
competent to bind ATP. An early report identi-
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Figure 4. CFTR NBD1 dynamics. (A) Root mean square fluctuations (RMSFs) of every residue in NBD1 as a
function of time, obtained from MD simulations. The vertical dotted line indicates fluctuations of the SDR loop.
Black arrows represent RMSF peaks for the corresponding structural regions in the plot. The ATP-binding core
subdomain (A, G451–L475; B, D565–Q637) and g-switch (Q493–P499) are colored green and labeled by the
bold lines at the top for reference. (B) Pairwise Ca correlation map for residues 490–560 in comparison with
those of all other regions in NBD1. Horizontal dotted lines separate the ATP-binding core subdomain (A and B)
and g-switch, as indicated by the bold lines on the left of the y-axis. The vertical dotted line corresponds to
position F508. The shift in the y-axis of the F508del–DRI correlation map is a consequence of RI deletion. Red
dots (correlation coefficient ¼ 1) indicate residue pairs that move in concert in the same direction, and blue dots
(correlation coefficient ¼ 21) indicate residue pairs that move with opposite velocities all the time. (C)
Structural model of full-length CFTR (http://dokhlab.unc.edu/research/CFTR/home.html). The area of the
NBD1–ICL3–ICL4 interface is shown in the inset. (D) A detailed view of the location and orientation of the
residues in the NBD1–ICL3–ICL4 interface from C . Residues F508, P499, M498, and E543 from NBD1
(salmon), S1058 and T1057 from ICL4 (blue), and K968 from ICL3 (cyan) are shown as spheres. (From
Aleksandrov et al. 2010; reproduced, with permission.)
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450 through 516 of NBD1 that could bind to
ATP with submillimolar affinity (Thomas et
al. 1991). Subsequently, a fragment comprising
residues 404–589 was shown to be capable of
folding and binding to ATP with an affinity
of 90 mM (Qu et al. 1997). This fragment
is missing the first b-strand of NBD1 and the
carboxy-terminal portion of the ATP-binding
core. More recently, in vitro translation experi-
ments monitored by fluorescence resonance en-
ergy transfer confirm that NBD1 residues 389
through 500, which comprise the b-subdomain
and parts of the ATP-binding core, can fold au-
tonomously into a subdomain that can bind to
ATP (Khushoo et al. 2011). This study further
showed that ATP stimulates proper folding
of this fragment. The ATP-binding capacity of
these NBD1 fragments suggests that these frag-
ments can form folded structures. However,
they are unlikely to assume the conformation
observed in the ground state structures, as crit-
ical portions are missing in each instance. Thus,
these fragments may form nonnative confor-
mations that may be in equilibrium with the
ground state conformation in the context of
the full-length NBD1, providing insight into
the accessible energy landscape.
In summary, NBD1 stability and changes in
the energetic landscape of NBD1 on deletion
of F508 are likely a critical part of the F508 defect.
Suppression of the processing defect by stabiliz-
ing mutations and low-temperature rescue sup-
port the key role these changes in NBD1 dynam-
ics play intheF508defect. CFTRchannelopening
and closing has been shown to be tightly cou-
pled to ATP binding and hydrolysis at the NBDs
(Csanady et al. 2009). The challenge for the fu-
ture will be to understand at a molecular level
how the nucleotide-binding status of the NBDs,
dimer conformation, and dynamics are alloste-
rically linked to MSD conformation and chan-
nel gating. It will also be interesting to see how
the absence of NBD2 will affect these linkages.
CONCLUDING REMARKS
CFTR shows a wide range of dynamics that en-
able proper folding and gating. The MSDs and
ICDs likely rearrange in response to activation
by PKA phosphorylation and in response to nu-
cleotide binding by the NBDs, forming a closed
state, an open-ready state, and an open state. The
precise nature of these conformational changes
awaits higher-resolution electron microscopy
images and more channel-gating experiments
building on already extensive studies. MSD in-
teractions with NBD1 via the ICDs are required
for proper folding and gating. Disruption of
ICD and NBD1 interactions is one mechanism
by which F508del disrupts folding and gat-
ing. F508del also appears to alter the transient
and complex dynamic interactions between
the NBD1 and the highly flexible, disordered
phosphoregulatory elements of CFTR that in-
clude the R region, RI, and RE, further impair-
ing channel gating. NMR data-based computa-
tional models of these regulatory interactions
will be useful for understanding exactly how
the phosphoregulatory elements and their reg-
ulatory interactions are changed by phosphory-
lation and how they are affected by deletion of
F508. NBD1 itself is highly dynamic. Although
F508del causes only minor changes to the NBD1
ground state structure, it alters the stability, fold-
ing pathway, and binding properties of this mar-
ginally stable domain. Avariety of data indicate
that F508del changes the energy landscape for
this domain and alters the frequency with which
higher energy states are accessed. The dynamics
and thermodynamics of NBD1 remain exciting
areas of study, both because changes in NBD1
dynamics have been directly linked to mispro-
cessing, instability, and channel-gating defects
and because some of these higher energy states
may have functional relevance. As such, infor-
mation about dynamics will be key for building a
model to describe how the R region and NBDs
allosterically control the MSDs and channel ac-
tivity. In addition, knowledge of the dynamics
involved in domain and full-length CFTR fold-
ing and interactions with cellular processing
machinery will be critical for mechanistic un-
derstanding of the F508del defects.
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